The size of the Middle East & Africa Prosthetic Heart Valves Market has been calculated at USD 1.24 billion in 2022. It is estimated to be growing at a CAGR of 12.11% and worth USD 2.20 billion by 2027.
Almost 300,000 valve replacements are done worldwide in a year, which may be mechanical valves or bioprosthetic valves. A prosthetic heart valve is a device that is implanted in a patient suffering from valve failures in the heart or other heart diseases which puts the patient at risk of heart failure. They are implanted both as a pre-emptive treatment and a reactive treatment. They may be used as both a method of prevention or a cure.
Artificial valves must be designed to perform all the functions of a normal native valve as well as withstand the adversities faced by introducing a foreign element into the body. Functions that the valve must perform include maintaining the unidirectional flow of blood in the body and proper opening and closing of the valves according to the body’s demand. Additionally, it must withstand the test of time as valve replacement on a regular basis is not feasible.
The rise of the Prosthetic Heart Valves market is mainly driven by the increasing aging population as well as the population affected by heart diseases. The technological advancements in the field, rise in prevalence of heart diseases due to changing lifestyles and ease of availability of medical centers performing open-heart surgery and awareness about heart diseases are other drivers of the market. However, the market growth is hampered by factors such as high cost of development, the lack of skilled professionals, reimbursement issues, post-treatment difficulties faced and strict government regulations.
This research report on the Middle East and Africa Prosthetic Heart Valves Market segmented and sub-segmented into the following categories:
By Product:
By Country:
The Middle-East & African market is one of the smallest market players owing to the underdeveloped nature of many countries in the region. The CAGR for the region is less than the global average mainly due to the lack of any noteworthy development in the field in African nations. In spite of the slow growth, the market is expected to prosper in the forecast years.
Companies playing a crucial role in the MEA Prosthetic Heart Valves Market are Corvia Medical, CardioKinetix, Biomerics LLC, Lepu Medical Technology, XELTIS BV, Comed BV, HLT, Meril Life Sciences, SYMETIS SA and Transcatheter Technologies.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Mechanical Heart Valve
5.1.3 Tissue Heart Valve
5.1.4 Transcatheter Heart Valve
5.1.5 Y-o-Y Growth Analysis, By Type
5.1.6 Market Attractiveness Analysis, By Type
5.1.7 Market Share Analysis, By Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Corvia Medical
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 CardioKinetix
8.3 Biomerics LLC
8.4 Lepu Medical Technology
8.5 XELTIS BV
8.6 Comed BV
8.7 Meril Life Sciences
8.8 SYSMETIS SA
8.9 HLT
8.10 Transcatheter Technologies GmbH
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
